Corneal diseases such as scars, degenerations, dystrophies, bullous keratopathy, and band-shaped keratopathy (BSK) are important causes of visual blindness; anterior stromal disease being superficial can be treated using various minimally invasive surgical procedures like lamellar keratoplasty (LKP) or superficial keratectomy or by excimer lasers, that is, phototherapeutic keratectomy (PTK).[1–11] PTK can be considered to be a bridge between medical and surgical management of corneal diseases. PTK can be used for therapeutic and / or refractive indications. This review deals with therapeutic indications for PTK. In this review, we highlight the indications of PTK, the technique, and management.
A Medline search was carried out for articles in the English language up to October 2010, with keywords such as phototherapeutic keratectomy, band-shaped keratopathy, spheroidal degeneration, scars, bullous keratopathy, and corneal dystrophy. PTK was performed with an excimer laser (193 nm) and worked on the principle of photoablation, by breaking the bonds between the molecules. One pulse of laser removed 0.25 microns of corneal tissue, making it more precise, while keeping the tissue removal depth under better control; also, the treated surface was smooth and regular, improving the visual outcome. The goals of PTK were to improve corneal surface irregularities, remove or reduce the density of the deposits, and alleviate symptoms such as recurrent corneal erosions (RCE), in the superficial corneal lesions; PTK, therefore, gave a clear visual axis, improving vision, or improved symptoms, or both; The broad beam laser was used initially and now flying spots lasers are used. Also, PTK was shown to be safe and effective in children for visual improvement and relief of symptoms of pain, irritation and photophobia.
Preoperative Selection of a Patient
The key to a successful outcome depends on proper case selection. Systemic diseases such as uncontrolled diabetes, collagen vascular diseases like rheumatoid arthritis, and systemic lupus erythromatosus may have delayed epithelial healing. The ocular selection criteria depend upon the corneal disease pathology, such as, the site, size, and depth, whether there is progressive-like dystrophy (progressive) or a scar (nonprogressive)-associated symptom (pain, watering, foreign body sensation, etc.), and preoperative refractive error. Corneal diseases limited to anterior stroma are amenable to treatment. Mitomycin C (MMC) is used as an adjunctive treatment to prevent recurrences. PTK improves symptoms of pain, watering, and foreign body sensation in RCE, in dystrophies, bullous keratopathy, and spheroidal degeneration.[61519–21]
Visual improvement after PTK is due to reduced density or removal of a scar and reduced irregular astigmatism. The PTK procedure must not be compared with Photorefractive keratectomy (PRK) where the uncorrected visual acuity (UCVA) improves. In fact, there may be a reduction in UCVA due to induced refractive errors, but the best corrected visual acuity (BCVA) improves. The clear cornea may help in accurate keratometry for intraocular lens (IOL) power calculation.
Therapeutic Indications [Table 1]
Spheroidal degeneration clinically presents in two forms; smooth fine gelatinous dew-drop appearance and yellow, raised spherules, with an irregular surface [Fig. 1]. The two forms may co-exist. The material is present in the sub-epithelial layer, Bowman's membrane, and superficial stroma. The irregularity affects the vision, and causes repeated epithelial breakdowns resulting in pain and photophobia, and predisposes the cornea to infections. Sridhar et al., have reported the proximity of an infiltrate close to the spherules, necessitating treatment, irrespective of their location. The management options include superficial keratectomy (manual or laser), with or without amniotic membrane grafts (AMG). LKP or penetrating keratoplasty (PKP) may be required for deeper involvement. PTK removes the spherules, resulting in a smoother surface, thus alleviating the symptoms. Badr et al., has shown that PTK has been successful in reducing corneal opacification in both smooth and rough spherules in 75 eyes with a clear-to-mild hazy cornea, in a smooth form, compared to the irregular form; 21% had delayed healing and 10% had infectious keratitis, with irregular spherules, as compared to smooth spherules, where delayed healing was noted in 9% and infectious keratitis in 1.8%. Spherules treated prior to cataract surgery resulted in better intraoperative visualization and patient satisfaction.
Salzmann nodular degeneration
Salzmann nodular degeneration (SND) is characterized by the presence of bluish-white peripheral nodules raised above the corneal surface, slowly progressive, more common in females with longstanding scars and chronic uveitis. The raised surface may be associated with tear film abnormality, irregular astigmatism, and difficulty in contact lens fitting. Surgery is the only treatment. The nodules are removed either by manual excision or by PTK. The outcome is better with superficial SND, when the Bowman's membrane is not touched, as against deeper SND, where more ablation is required. The induced myopia, after removal of the peripheral nodules, is not because of PTK, but because of the manual removal of nodules. Khaireddin et al., had used MMC 0.02% for 30 seconds in patients with SND, after PTK, as also superficial keratectomy, to prevent recurrence. The epithelium is metabolically active in these patients. MMC inhibits DNA synthesis and prevents further proliferation in these patients.
Clinically these present in two varieties, smooth and rough. In smooth BSK, the calcified material is at the Bowman's membrane level with a stable epithelium above it. The treatment includes removal of deposits either with Ethylenediaminetetraacetic acid (EDTA), superficial keratectomy or PTK.[1032–34] PTK is effective in BSK when performed for symptomatic relief or for vision improvement; but some authors have not found improvement after PTK [Fig. 2a, b].
Bullous keratopathy is characterized by bullae formation and its rupture, resulting in symptoms of pain, foreign body sensation, watering. The treatment is two-fold symptomatic relief and visual improvement. The first goal of symptomatic relief is with hyperosmotic agents, bandage contact lens (BCL) or with anterior stromal puncture (ASP), AMG, PTK, ASP with AMG, and PTK with AMG.[152035–38] The second goal is visual improvement. PTK is a very promising and effective treatment for bullous keratopathy and can also be repeated. Deeper ablations give more symptomatic relief than superficial shallow ablations. Nerve endings are ablated with deeper ablations and pain is less. With a deeper ablation of 25% of corneal thickness, better alleviation of symptoms is noted as compared to the superficial and intermediate. Bullae formation may occur outside the area of the ablation.
Phototherapeutic keratectomy is indicated for anterior basement membrane dystrophies and stromal dystrophies for both symptomatic relief and visual improvement.[41–48] It is also tried in cases of Fuchs’ endothelial dystrophy for subepithelial scarring or for removal of a substantial part of the stroma, to reduce the load on the endothelium. All these indications are done with a varying success rate and a varying rate of recurrence. Dystrophies being central, the ablation profile of PTK mimics myopic correction and thereby induces hyperopia. This depends on the amount of ablation depth. Also, intraoperative application of MMC helps prevent recurrences.[49–51]
- Map dot finger print dystrophy: PTK is indicated for RCE or reduced vision because of irregular astigmatism or both.[4152–54] Early recurrences are noted at six-to-nine months or a year or more.
- Granular Dystrophy: PTK is the first line of treatment as recurrence is slow. Also, the ocular surface health is better after PTK.
- Macular dystrophy: The deeper deposits persists after PTK and recurrences are heavy so PKP should be preferred.
- Lattice dystrophy: PTK is indicated for repeated RCE and later on for a scar.
- Schnyder's dystrophy: PTK is also performed for Schnyder's dystrophy.
- Avellino dystrophy gets worsened or aggravated if PTK is done.
Recurrent corneal erosion
Recurrent epithelial breakdown occurs when the epithelial attachments to the underlying stroma are loose.[60–62] It is characterized by sudden onset of pain in the eyes, usually on awakening in the morning, associated with redness, watering, and photophobia. The episodes of RCE may vary in the intensity of symptoms and erosion may show a slipped-rug appearance. RCE is managed by lubricants, BCL, oral doxycycline, topical corticosteroids, ASP or PTK.[55606163–66] The main goal is to form adhesion complexes between the epithelium and stroma by ablation of the Bowman's layer.
The excimer laser is also used in a persistent epithelial defect or shield ulcers. Ablation is performed at the elevated edges of the defect so that epithelial cells migrate to cover the defect.
Superficial anterior stromal avascular scars (less than 100 microns), are amenable to treatment by PTK. These scars may be post-traumatic, post-infectious or post-pterygium excision. The aim is to improve vision and delay or obviate the need for keratoplasty. Scars after healed bacterial or fungal keratitis can be treated with PTK. Scars post-viral keratitis need to be treated with caution because of risk of recurrence after PTK.
The outcome is comparable between post-traumatic and post-infectious scars. Migden et al., have shown a significant improvement in visual acuity in 50% of the cases of post-traumatic scars (4 / 8 eyes) as against 0 / 5 eyes with post-infectious scars. Fagerholm et al., have shown a success of 67% in post-traumatic scars and 80% in post-herpetic scars. Sher et al., have shown improvement in 5 / 8 eyes with post-traumatic scars and 3 / 5 eyes with post-infectious scars. Campos et al., have shown good visual outcome in post-traumatic as against post-infectious scars, but the number is quite less.
Scars post-pterygium surgery can be treated either as a primary scar or as a topography-guided treatment, with correction of irregular astigmatism. PTK is indicated for scars of previous refractive surgeries and nodular sub-epithelial scars of keratoconus.[7477–79] Elsahn et al., had performed PTK in 15 eyes of keratoconus patients with nodules who were contact lens–intolerant. Eleven were successfully refitted with the contact lens, but three patients had recurrence of the nodule and one patient underwent re-PTK for the same.
Phototherapeutic keratectomy was shown to be effective in the management of microbial keratitis of bacterial, fungal, viral, and parasitic origin.[80–84] Most bacterial keratitis responded well to the treatment. Lindbohm et al., had performed PTK in the interface after lifting and rinsing the flap, in a patient who had infectious keratitis after laser-assisted in situ keratomileusis (LASIK). The authors concluded that PTK could be helpful in these cases, when the ulcer did not respond to the topical or oral antibiotic treatment.
Phototherapeutic keratectomy can be performed for both superficial and deep fungal infections. The advantages are reduction in the duration of treatment, fastened re-epithelization, along with debulking, and improving drug penetration, especially in deeper infections. The medical treatment should be continued if required. The complications are perforation of the cornea during PTK. This is because of the different ablation rates of the cornea in the presence of infection and corneal edema. The other complications include irregular astigmatism resulting in reduction in visual acuity, hyperopic shift, delayed epithelial healing, haze, and scarring, as steroids are not advised in active infection, and the ablation is deeper.
Unresponsive acanthamoeba keratitis can be treated with PTK. The advantage is the direct removal of the amoebic cysts. PTK should be performed early; if delayed, the infection would go to the deeper level, which would need more ablation and would increase the risk of perforation. The focus of infection should be removed completely. The residual amoebic lesion could worsen and a repeat PTK procedure would have to be performed. The end point is difficult to judge on diffuse illumination and one may have to move the patient repeatedly to the slit lamp to examine the surface or may use the sclerotic scatter illumination technique for better visualization of the opacity and avoid the excessive ablation.
The main diagnosis and planning of PTK is based on clinical judgment, on slit lamp examination, and the amount of refractive error. Hyperopic refraction before PTK for central corneal disease will increase the amount of hyperopia and may result in anisometropia, warranting a contact lens trial. Imaging techniques are used to plan and manage the postoperative outcome.
Corneal topography helps in the planning and following up of patients after a PTK procedure. It also helps in correcting the pre-existing refractive error by the topography-guided laser treatment. This helps in reducing irregular astigmatism and improving visual acuity. Vinciguera et al., have conducted PTK with corneal topography-based aberrometry after epithelial debridement and achieved good results.
Ultrasound biomicroscopy (UBM) uses a high frequency ultrasound to produce high resolution images of the cornea. The UBM measurement overestimates the corneal pathology, and the ablation required is inversely proportional to the depth of the pathology and does not help in the planning of the procedure.
Ocular coherence tomography
Ocular coherence tomography (OCT) is a noncontact, cross-sectional, high-resolution representation of cornel configuration, before and after PTK. The quantitative differences in the epithelial thickness after PTK can be monitored for epithelial hyperplasia and anterior stromal changes. OCT is used to measure the depth of opacities in the cornea and it helps in the planning of either a lamellar or a penetrating procedure depending on the depth of the opacities [Fig. 3].
Technique of Phototherapeutic Keratectomy
The technique of PTK varies according to the underlying pathology, size, and site. Hence, it is better explained as a common method first and then the specific technique in the specified pathology can be modified as described.
General technique of the phototherapeutic keratectomy procedure
The procedure is generally done under topical anesthesia, unless some additional surgical procedure is combined with PTK (local anesthesia) or when the procedure is done in pediatric patients, general anesthesia may be required. The topical anesthetic agents used are Xylocaine 4% or Proparacaine HCl (0.5%). We usually use three to four drops at an interval of two minutes each, just before the procedure. Written informed consent is taken from the patients or guardian. The procedure is done under strict aseptic precautions. After applying the wire speculum, the epithelium is debrided manually with a hockey stick knife. The epithelium comes out easily in bullous keratopathy. Some surgeons do use alcohol for the debridement of the epithelium. After debriding the epithelium, ablation is performed either by asking the patient to look into the green fixation light or a laser is centered manually. In an eccentric or peripheral lesion, the surgeon needs to manually rotate the patient's head or eye for ablation. If the surface is rough, a masking agent such as hydroxypropyl methylcellulose (HPMC) 0.7 to 2% is spread to smooth the cornea. This masks the deeper tissue and only the protruding irregularities of the cornea are exposed for laser ablation. Kornmehl et al., have compared three masking fluids with different viscosities and found that dextran 0.1% provides the smoothest postoperative surface. We routinely use 0.7% HPMC. Masking fluids need to be applied intermittently during the procedure, although applying fluid too many times will delay the procedure and may further increase the irregularities of the surface after the procedure. The sharp edge of ablation can be avoided by using the polishing technique by annular motion of the eye under a laser and by avoiding the point shooting. A few visual and auditory signals during the procedure may help in guiding the extent of the treatment. A snapping sound is heard when the tissue is ablated, and when the masking fluid gets ablated, a soft sound is heard. A bubbling sound indicates too much of methylcellulose. Similarly, the ablation of the epithelium shows blue fluorescence in the dark room, while stromal ablation does not produce blue fluorescence. This gives a guideline for the depth of ablation. After firing 70 to 80% of the target ablation, the patient must be examined on the slit-lamp. Some machines have in-built slit-lamps, so that one does not have to move the patient from the machine to the slit lamp. This is necessary to protect over-ablation of thin areas and to decide about additional treatment if needed. The endpoints for superficial opacities are usually the visible iris details. Granularity may remain with spheroidal degeneration. MMC can be used intraoperatively.
Technique: Specific to etiology
The ablation rate of a corneal scar is different as compared to normal corneal stroma; meticulous planning is required when faced with special scenarios, as follows:
- Spheroidal degeneration: The smooth spherules can be treated similar to PRK, by centering the ablation on the cornea after epithelial debridement, either on a wet or dry surface. Large single zone ablations of 6 mm or more usually suffice. Masking fluid is used when the surface is irregular. The rough spherules are treated first directly and then with a large single zone polishing ablation. The end point is a relatively clear cornea with some granularity.
- Salzmann nodular degeneration: The nodules are treated directly with a small ablation zone diameter after the epithelial debridement [Fig. 4]. Sometimes it is easy to remove the nodules with a smoother surface manually, but when this is difficult, ablation is to be titrated according to the irregular surface with the use of masking fluid. Once the nodules are ablated, an overall larger ablation zone diameter can be used to have an overall smooth corneal surface. It may not be possible to completely clear the cornea, but the surface will be smoother.
- Corneal Dystrophies: As the dystrophies involve the central cornea, treatment is targeted to the central 6 mm to 7 mm.[10a92] The endpoint is not to remove all the deposits, but to reduce the density of the deposits, clear the visual axis, and remove surface irregularities. Kim et al., have described the use of MMC in four patients over a follow-up of a year; but recent studies have shown that the recurrences are severe when MMC is used with PTK over a long follow-up.
- Bullous keratopathy: The epithelium being very loose comes off easily with a surgical sponge. A large ablation is performed either on a dry or wet surface, to have a wider area of healing. The cornea being thick, about a 100-micron ablation can be done to have stronger epithelial adhesions and reduced pain after PTK.
- Recurrent corneal erosions: The epithelium is debrided manually so that the adhesions formed are better. RCE may occur as a sequel to trauma, dystrophies or spontaneously. Furthermore, the amount of ablation may range from 3 microns in RCE due to trauma, to 100 microns in RCE in bullous keratopathy and cornea dystrophies like lattice. In shallow ablations, the haze formation is less. With an ablation of five microns, there is no induced astigmatism and treatment can be done in the center or periphery without significant refractive shifts.
- Band-shaped keratopathy: The laser can be fired directly in the center of the cornea over 6 – 7 mm after epithelial debridement. Masking fluid may be required. As calcium has a lower ablation rate, more pulses are required for PTK. Smooth BSK can be treated directly with a single large ablation zone. O’Brart et al., have performed PTK on an intact epithelial surface, with cessation of brighter fluorescence with treatment, the treatment was stopped in a smooth BSK. In a rough BSK, multiple overlapping ablation zones are required, with intermittent mechanical debridement of the epithelium, to smoothen the surface. Large calcified plaques should be removed with a blade. With the resultant irregular surface, the troughs should be filled with the masking fluid and the laser should be done later.
- Scars: The location of scars in the cornea (central or peripheral) is important. The central scar can be treated with the general technique. For peripheral scars, the eye has to be rotated manually to center the treatment over it or PTK can be performed using a joystick-controlled platform like Technolas 217z. Associated irregular astigmatism can best be treated with topography-guided PTK.
Phototherapeutic keratectomy should be limited to the anterior corneal lesions only, as deeper scars need deeper ablations and may result in a more haze formation. The best candidates are patients with opacities in the anterior 10 – 20% of the cornea, without significant irregularity and thinning. Patients who have both superficial and deep stromal lesions, only superficial lesions are easily treated as shown by Paparo et al. Also, complete treatment is not possible. Systemic diseases such as diabetes mellitus and autoimmune disorders are contraindications for PTK. The decreased corneal sensation may affect epithelial healing, with an increased risk of melt. Any viral activity within last six months is a contraindication.
Post Phototherapeutic Keratectomy Management
Poor epithelial healing would result in haze formation or infection. Either BCL such as the Silicone hydrogel lens or patching of the eye is required to facilitate the healing. Prophylactic antibiotic eye drops such as newer generation fluoroquinolone is instilled till the epithelium heals, and the BCL is removed. If the eye is patched, then antibiotic ointment is instilled twice a day with the patch, till the epithelium heals. Topical NSAIDs such as Diclofenac sodium, reduce postoperative pain and do not affect the healing of the epithelium and may reduce the need for oral analgesics. Oral analgesics can be given as required. However, NSAIDs must be used with caution as topical nepafenac is reported for corneal melt after PRK. Once the defect heals and BCL is removed, topical corticosteroids such as Fluorometholone alcohol must be given four times daily, tapered by one drop per week, over a month. Topical lubricants are prescribed for a month, four to six times daily.
Phototherapeutic keratectomy combined with or before and after other surgeries
Phototherapeutic keratectomy combined with amniotic membrane grafts
Amniotic membrane grafts are being used extensively in various ocular surface disorders, as they result in a smooth surface, rapid epithelization, reduced inflammation, and scarring. Post PTK anterior stromal scarring depends upon the depth of the ablation and the duration of epithelial defect healing. Wang et al., have shown that an AMG-covered cornea had minimal inflammation and no keratocyte apoptosis on days one and seven, after photoablation in rabbit eyes, resulting in minimal haze formation. Choi et al., have shown that AMG promotes rapid epithelization in rabbit eyes. PTK can be combined with AMG for severe subepithelial fibrosis after PRK, in painful bullous keratopathy, SND, scars, and spheroidal degeneration. It reduces pain and prevents bullae formation.
Phototherapeutic keratectomy after pterygium surgery
Phototherapeutic keratectomy is combined with bare sclera excision of the pterygium. Good visual recovery is reported when PTK is performed with ablation to a depth of 40 – 80 microns, to smoothen the cornea, and 10 microns on the limbus and bare sclera, to remove the residual tissue in the recurrent pterygium, and recurrence was noted in one eye two months postoperatively and over a follow-up of one year for 20 patients. When PTK and pterygium excision is combined with topical MMC (0.02%) twice daily, for four days; 2.9 and 6.4% recurrences are noted in the primary and recurrent pterygia.
Phototherapeutic keratectomy before and after penetrating keratoplasty
Phototherapeutic keratectomy is indicated in patients who have recurrences of dystrophy after PKP. In macular dystrophies, PTK can improve the visual acuity for a limited period and recurrences are known to necessitate PKP later. PTK is shown to be effective in granular and lattice dystrophy before PK, with good clinical outcome in granular dystrophy. Similarly, with recurrences of dystrophy after PTK, repeat PTK can be performed and keratoplasty can be considered when the cornea is too thin to tolerate the repeat PTK. Park et al., have performed deep anterior lamellar keratoplasty in four patients who had recurrence of Avellino dystrophy after PTK, with a good surgical outcome. Szentmary et al., have shown that a preceding PTK does not affect the outcome of PKP. Descemet stripping endothelial automated keratoplasty (DSAEK) is a preferred technique nowadays, in patients with endothelial dysfunction. In these patients, PTK is shown to be effective for the treatment of subepithelial fibrosis. There is a report of PTK being performed for the subepithelial fibrosis along with the use of MMC after DSAEK.
Phototherapeutic keratectomy before cataract surgery
Phototherapeutic keratectomy prior to cataract surgery helps in multiple ways. The presence of corneal opacities may interfere with intraoperative visualization and postoperative patient satisfaction. As the surface becomes smooth after PTK, keratometry or corneal topography is possible, with better accuracy [Fig. 5]. PTK is indicated before cataract surgery in patients with spheroidal degeneration and BSK.
Clinical outcome is defined either as a reduction or amelioration of symptoms and / or clarity of visual axis. The clinical outcome may vary depending on the pre-existing corneal disease. Spheroidal degeneration may have residual granularity after PTK. SND may have a residual scar; the pre-existing scar is deeper and smooth, and the haze is superficial in the area of ablation.
Residual deposits may remain in the cornea, but frequency of RCE is reduced in dystrophies and also the visual axis is relatively clear. Lattice, Macular, and Granular dystrophies are known to recur. The patient may have good vision even in the presence of a recurrence. Clinically significant recurrences may not need further intervention, unless it becomes a cause for visual disturbance [Fig. 6].
Best corrected visual acuity (BCVA) improves and Uncorrected Visual Acuity (UCVA) may reduce after PTK, because of the induced refractive error. Occasionally, PTK may be combined with PRK and vision may improve in those patients. The visual outcome may be unaffected when PTK is performed, to give symptomatic relief, as in bullous keratopathy. The visual improvement may depend upon the co-existing ocular disease.
A significant amount of tissue removal will induce refractive error, the type and amount depends on the site and depth of ablation; central ablation will flatten the cornea and induce a hyperopic shift, like a photorefractive keratectomy, similarly peripheral ablation will result in removal of tissue in the periphery, like hyperopic ablation, and will induce myopia. Ablations above 85 – 100 microns show a hyperopic refractive shift. Starr et al. have shown a refractive shift of more than or equal to 1 D in 63% of the patients. This hyperopic shift can be reduced by a standard peripheral transition zone of 0.5 D. The ablation also depends upon the corneal hydration, and drying of the cornea during the procedure may induce more hyperopia; this is important for a novice surgeon, as the delayed treatment time would reduce the stromal thickness and in turn increase ablation. Usually the refraction gets stabilized after three months.
Amm et al., had found lack of refractive changes when spot mode was used for ablation. PTK with PRK was reported as in scars, dystrophy, Thygeson's superficial punctuate keratopathy, and diffuse lamellar keratitis.
Repeat Phototherapeutic Keratectomy
Clinical recurrences may not warrant repeat treatments, whereas, in a visually significant recurrence (reduced BCVA by more than two lines), PTK can be repeated, provided corneal thickness is enough and the corneal topography does not show too much flattening.
Recurrence of primary disease pathology
Corneal dystrophies and RCE recur. Reis Buckler dystrophy has a high rate of recurrence. Miller et al., have tried topical intraoperative MMC, to avoid recurrence of Reis Buckler dystrophy, stating that fibrocellullar material replaces the Bowman's layer, which is analogous to neoplastic proliferation. With the high rate of recurrence after PTK for macular dystrophy, PKP must be the first line of treatment for macular dystrophy and PTK can be performed during the waiting period. Recurrence has been reported in BSK, in nine eyes (five with silicone oil) out of the 122 treated eyes. Dinh et al., have noted no recurrence in Schnyder's dystrophy over a short follow-up and Koksal over the longest follow-up of 68 months. Paparo et al., have reported recurrence after a year in the periphery, in Schnyder's dystrophy. PTK can be repeated till the final limit of 250 microns is reached to avoid keratectasia, and PKP could be considered then.
al-Rajhi et al., have reported three cases of bacterial keratitis after PTK in three out of 258 patients of spheroidal degeneration, over one to 24 months. Even when PTK is successful, the occurrence of infectious keratitis can adversely affect the final visual outcome. Fagerholm has reported bacterial keratitis between one to eight weeks after surgery and believed it to be because of RCE.
Reactivation of herpes simplex virus
Spontaneous reactivation of the virus could occur after PTK. Viral shedding was noted in one patient of BSK three days after PTK, without any clinical signs, and the authors concluded that excimer laser irradiation might elicit HSV reactivation. Vrabec et al., reported recurrence of herpetic keratitis about three months after PTK, in patients with a past history of herpetic keratitis. Starr et al., have shown recurrence in their patients, 4, 14, and 17 months after PTK. The excimer laser emits at 193 nm and the UV radiation ranges between 180 and 450 nm. The ablation depth is not responsible for recurrence as also the epithelial removal. Also corneal trauma, postoperative pain, and topical steroid use may activate the virus. Herpes virus reactivation should be considered if the defect does not heal or there is a persistent epithelial defect after PTK. PTK for scars of Epidemic keratoconjunctivitis must be carried out when the eye becomes quiet, else recurrence can occur.
Delayed healing of epithelium
The epithelial defect usually heals within a week's time and delayed healing can increase the risk of infection and haze formation. This may need AMG along with lubricants and BCL especially in lattice dystrophy. Zuckerman et al., have noticed delayed healing in patients with corneal leucoma (8.1 ± 2.6 days). The causes of non-healing can be the concomitant use of topical NSAIDS or reduced corneal sensation.
Other complications reported are keratectasia, when PTK is done for nebulae of keratoconus. A larger ablation zone is recommended in thinner cornea, because of the uniform stress distribution, with less stress on a single, thin area. Permanent corneal edema following the use of 0.02% drops of MMC for six days after PTK in a young patient who had PTK for RCE, has been reported. Graft rejection has been reported after PTK.
Phototherapeutic keratectomy is a safe and effective procedure in the management of superficial corneal diseases such as corneal scars, degenerations, and dystrophies. It reduces RCE and improves vision. Also, as repeat PTK is possible, keratoplasty can be delayed or obviated. Even when visual improvement is not the goal, as in bullous keratopathy, PTK will result in having a firm adhesion of the epithelium to the underlying stroma, and may prevent bullae formation and RCE. The smooth surface obtained in spheroidal degeneration will help in improving the visual acuity, also keratometry or topography is more precise for IOL power calculation when these patients undergo cataract surgery.
With the better overall outcome of PTK procedures, the research should be directed toward preventing recurrences of primary disease pathology, and for better predictability of post-PTK refractive error and combining PTK with PRK for both good visual and symptomatic outcome, in the future, so that keratoplasties can be avoided. Also, the role of the AMG with PTK procedure must be studied.
Librarian: Ms Banu
1. Ayres BD, Rapuano CJ. Excimer laser phototherapeutic keratectomy Ocul Surf. 2006;4:196–206
2. Campos M, Nielsen S, Szerenyi K, Garbus JJ, McDonnell PJ. Clinical follow-up of phototherapeutic keratectomy for treatment of corneal opacities Am J Ophthalmol. 1993;115:433–40
3. Dogru M, Katakami C, Miyashita M, Hida E, Uenishi M, Tetsumoto K, et al Ocular surface changes after excimer laser phototherapeutic keratectomy Ophthalmology. 2000;107:1144–52
4. Fagerholm P. Phototherapeutic keratectomy: 12 years of experience Acta Ophthalmol Scand. 2003;81:19–32
5. Hersh PS, Burnstein Y, Carr J, Etwaru G, Mayers M. Excimer laser phototherapeutic keratectomy: Surgical strategies and clinical outcomes Ophthalmology. 1996;103:1210–22
6. Sharma N, Prakash G, Sinha R, Tandon R, Titiyal JS, Vajpayee RB. Indications and outcomes of phototherapeutic keratectomy in the developing world Cornea. 2008;27:44–9
7. Rapuano CJ. Excimer laser phototherapeutic keratectomy Curr Opin Ophthalmol. 2001;12:288–93
8. Starr M, Donnenfeld E, Newton M, Tostanoski J, Muller J, Odrich M. Excimer laser phototherapeutic keratectomy Cornea. 1996;15:557–65
9. Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C. Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutic keratectomy J Cataract Refract Surg. 2005;31:82–7
10. Rathi VM, Vyas SP, Vaddavalli PK, Sangwan VS, Murthy SI. Phototherapeutic keratectomy in pediatric patients in India Cornea. 2010;29:1109–12
10a. Vyas S, Rathi V. Phototherapeutic keratectomy for Granular dystrophy Asian J Ophthalmol. 2008;10:123–5
11. Dogru M, Katakami C, Miyashita M, Hida E, Uenishi M, Tetsumoto K, et al Visual and tear function improvement after superficial phototherapeutic keratectomy (PTK) for mid-stromal corneal scarring Eye. 2000;14:779–84
12. Maloney RK, Thompson V, Ghiselli G, Durrie D, Waring GO 3rd, O’Connell M. A prospective multicenter trial of excimer laser phototherapeutic keratectomy for corneal vision loss: The Summit Phototherapeutic Keratectomy Study Group Am J Ophthalmol. 1996;122:149–60
13. Moniz N, Fernandez ST. Efficacy of phototherapeutic keratectomy in various superficial corneal pathologies J Refract Surg. 2003;19:S243–6
14. Zuckerman SJ, Aquavella JV, Park SB. Analysis of the efficacy and safety of excimer laser PTK in the treatment of corneal disease Cornea. 1996;15:9–14
15. Vyas S, Rathi V. Combined phototherapeutic keratectomy and amniotic membrane grafts for symptomatic bullous keratopathy Cornea. 2009;28:1028–31
16. Autrata R, Rehurek J, Vodickova K. Phototherapeutic keratectomy in children: 5-year results J Cataract Refract Surg. 2004;30:1909–16
17. Kollias AN, Spitzlberger GM, Thurau S, Gruterich M, Lackerbauer CA. Phototherapeutic keratectomy in children J Refract Surg. 2007;23:703–8
18. Ayres BD, Hammersmith KM, Laibson PR, Rapuano CJ. Phototherapeutic keratectomy with intraoperative mitomycin C to prevent recurrent anterior corneal pathology Am J Ophthalmol. 2006;142:490–2
19. Badr IA, al-Rajhi A, Wagoner MD, Dunham T, Teichmann KD, Cameron JA. Phototherapeutic keratectomy for climatic droplet keratopathy, KKESH Excimer Laser Study Group. King Khaled Eye Specialist Hospital J Refract Surg. 1996;12:114–22
20. Thomann U, Meier-Gibbons F, Schipper I. Phototherapeutic keratectomy for bullous keratopathy Br J Ophthalmol. 1995;79:335–8
21. Maini R, Sullivan L, Snibson GR, Taylor HR, Loughnan MS. A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy Br J Ophthalmol. 2001;85:912–5
22. Amm M, Duncker GI. Refractive changes after phototherapeutic keratectomy J Cataract Refract Surg. 1997;23:839–44
23. Salah T, el Maghraby A, Waring GO 3rd. Excimer laser phototherapeutic keratectomy before cataract extraction and intraocular lens implantation Am J Ophthalmol. 1996;122:340–8
24. Sridhar MS, Garg P, Das S, Vemuganti G, Gopinathan U, Rao GN. Infectious keratitis in climatic droplet keratopathy Cornea. 2000;19:455–8
25. Rao SK, Fogla R, Seethalakshmi G, Padmanabhan P. Excimer laser phototherapeutic keratectomy: Indications, results and its role in the Indian scenario Indian J Ophthalmol. 1999;47:167–72
26. Saini JS, Jain AK, Sukhija J, Saroha V. Indications and outcome of optical partial thickness lamellar keratoplasty Cornea. 2003;22:111–3
27. Das S, Langenbucher A, Pogorelov P, Link B, Seitz B. Long-term outcome of excimer laser phototherapeutic keratectomy for treatment of Salzmann's nodular degeneration J Cataract Refract Surg. 2005;31:1386–91
28. Das S, Link B, Seitz B. Salzmann's nodular degeneration of the cornea: A review and case series Cornea. 2005;24:772–7
29. Meltendorf C, Buhren J, Bug R, Ohrloff C, Kohnen T. Correlation between clinical in vivo
confocal microscopic and ex vivo
histopathologic findings of Salzmann nodular degeneration Cornea. 2006;25:734–8
30. Oster JG, Steinert RF, Hogan RN. Reduction of hyperopia associated with manual excision of Salzmann's nodular degeneration J Refract Surg. 2001;17:466–9
31. Khaireddin R, Katz T, Baile RB, Richard G, Linke SJ. Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: A follow-up of eight eyes Graefes Arch Clin Exp Ophthalmol. 2011;249:1211–5
32. O’Brart DP, Gartry DS, Lohmann CP, Patmore AL, Kerr Muir MG, Marshall J. Treatment of band keratopathy by excimer laser phototherapeutic keratectomy: Surgical techniques and long term follow up Br J Ophthalmol. 1993;77:702–8
33. Stewart OG, Morrell AJ. Management of band keratopathy with excimer phototherapeutic keratectomy: Visual, refractive, and symptomatic outcome Eye. 2003;17:233–7
34. Fan DS, Chan CK, Cheng AC, Rao SK, Yu CB, Lam DS. Multistage approach to uveitic cataract management in children J Pediatr Ophthalmol Strabismus. 2006;43:172–5
35. Lin PY, Wu CC, Lee SM. Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy Br J Ophthalmol. 2001;85:908–11
36. Smiddy WE, Hamburg TR, Kracher GP, Gottsch JD, Stark WJ. Therapeutic contact lenses Ophthalmology. 1990;97:291–5
37. Sonmez B, Kim BT, Aldave AJ. Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential Cornea. 2007;26:227–9
38. Gomes JA, Haraguchi DK, Zambrano DU, Izquierdo Júnior L, Cunha MC, de Freitas D. Anterior stromal puncture in the treatment of bullous keratopathy: Six-month follow-up Cornea. 2001;20:570–2
39. Rosa N, Cennamo G. Phototherapeutic keratectomy for relief of pain in patients with pseudophakic corneal edema J Refract Surg. 2002;18:276–9
40. Thomann U, Niesen U, Schipper I. Successful phototherapeutic keratectomy for recurrent erosions in bullous keratopathy J Refract Surg. 1996;12:S290–2
41. Cavanaugh TB, Lind DM, Cutarelli PE, Mack RJ, Durrie DS, Hassanein KM, et al Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy Ophthalmology. 1999;106:971–6
42. Das S, Langenbucher A, Seitz B. Delayed healing of corneal epithelium after phototherapeutic keratectomy for lattice dystrophy Cornea. 2005;24:283–7
43. Dinh R, Rapuano CJ, Cohen EJ, Laibson PR. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy Ophthalmology. 1999;106:1490–7
44. Dogru M, Katakami C, Nishida T, Yamanaka A. Alteration of the ocular surface with recurrence of granular/avellino corneal dystrophy after phototherapeutic keratectomy: report of five cases and literature review Ophthalmology. 2001;108:810–7
45. Hafner A, Langenbucher A, Seitz B. Long-term results of phototherapeutic keratectomy with 193-nm excimer laser for macular corneal dystrophy Am J Ophthalmol. 2005;140:392–6
46. Ciancaglini M, Carpineto P, Doronzo E, Nubile M, Zuppardi E, Mastropasqua L. Morphological evaluation of Schnyder's central crystalline dystrophy by confocal microscopy before and after phototherapeutic keratectomy J Cataract Refract Surg. 2001;27:1892–5
47. Herring JH, Phillips D, McCaa CS. Phototherapeutic keratectomy for Schnyder's central crystalline dystrophy J Refract Surg. 1999;15:489
48. Nassaralla BA, Garbus J, McDonnell PJ. Phototherapeutic keratectomy for granular and lattice corneal dystrophies at 1.5 to 4 years J Refract Surg. 1996;12:795–800
49. Kim TI, Pak JH, Chae JB, Kim EK, Tchah H. Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy Cornea. 2006;25:220–3
50. Marcon AS, Rapuano CJ. Excimer laser phototherapeutic keratectomy retreatment of anterior basement membrane dystrophy and Salzmann's nodular degeneration with topical mitomycin C Cornea. 2002;21:828–30
51. Miller A, Solomon R, Bloom A, Palmer C, Perry HD, Donnenfeld ED. Prevention of recurrent Reis-Bucklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C Cornea. 2004;23:732–5
52. Orndahl MJ, Fagerholm PP. Phototherapeutic keratectomy for map-dot-fingerprint corneal dystrophy Cornea. 1998;17:595–9
53. Pogorelov P, Langenbucher A, Kruse F, Seitz B. Long-term results of phototherapeutic keratectomy for corneal map-dot-fingerprint dystrophy (Cogan-Guerry) Cornea. 2006;25:774–7
54. Zaidman GW, Hong A. Visual and refractive results of combined PTK/PRK in patients with corneal surface disease and refractive errors J Cataract Refract Surg. 2006;32:958–61
55. Chow AM, Yiu EP, Hui MK, Ho CK. Shallow ablations in phototherapeutic keratectomy: long-term follow-up J Cataract Refract Surg. 2005;31:2133–6
56. Lee ES, Kim EK. Surgical do's and don’ts of corneal dystrophies Curr Opin Ophthalmol. 2003;14:186–91
57. Das S, Langenbucher A, Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: A comparative study J Refract Surg. 2005;21:727–31
58. Koksal M, Kargi S, Gurelik G, Akata F. Phototherapeutic keratectomy in Schnyder crystalline corneal dystrophy Cornea. 2004;23:311–3
59. Paparo LG, Rapuano CJ, Raber IM, Grewal S, Cohen EJ, Laibson PR. Phototherapeutic keratectomy for Schnyder's crystalline corneal dystrophy Cornea. 2000;19:343–7
60. Das S, Seitz B. Recurrent corneal erosion syndrome Surv Ophthalmol. 2008;53:3–15
61. Liu C, Buckley R. The role of the therapeutic contact lens in the management of recurrent corneal erosions: A review of treatment strategies Clao J. 1996;22:79–82
62. Maini R, Loughnan MS. Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome Br J Ophthalmol. 2002;86:270–2
63. Bernauer W, De Cock R, Dart JK. Phototherapeutic keratectomy in recurrent corneal erosions refractory to other forms of treatment Eye. 1996;10:561–4
64. Morad Y, Haviv D, Zadok D, Krakowsky D, Hefetz L, Nemet P. Excimer laser phototherapeutic keratectomy for recurrent corneal erosion J Cataract Refract Surg. 1998;24:451–5
65. O’Brart DP, Muir MG, Marshall J. Phototherapeutic keratectomy for recurrent corneal erosions Eye. 1994;8:378–83
66. Wang L, Tsang H, Coroneo M. Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid Clin Exp Ophthalmol. 2008;36:8–12
67. Ramamurthi S, Rahman MQ, Dutton GN, Ramaesh K. Pathogenesis, clinical features and management of recurrent corneal erosions Eye. 2006;20:635–44
68. Cameron JA, Antonios SR, Badr IA. Excimer laser phototherapeutic keratectomy for shield ulcers and corneal plaques in vernal keratoconjunctivitis J Refract Surg. 1995;11:31–5
69. Kim MS, Song SW, Kim JH, Woo HM. Multifocal phototherapeutic keratectomy for the treatment of persistent epithelial defect J Cataract Refract Surg. 2000;26:1753–7
70. Faktorovich EG, Badawi DY, Maloney RK, Ariyasu RG. Growth factor expression in corneal wound healing after excimer laser keratectomy Cornea. 1999;18:580–8
71. Sher NA, Bowers RA, Zabel RW, Frantz JM, Eiferman RA, Brown DC, et al Clinical use of the 193-nm excimer laser in the treatment of corneal scars Arch Ophthalmol. 1991;109:491–8
72. Fagerholm P, Fitzsimmons TD, Orndahl M, Ohman L, Tengroth B. Phototherapeutic keratectomy: Long-term results in 166 eyes Refract Corneal Surg. 1993;9:S76–81
73. Migden M, Elkins BS, Clinch TE. Phototherapeutic keratectomy for corneal scars Ophthalmic Surg Lasers. 1996;27:S503–7
74. Ward MA, Artunduaga G, Thompson KP, Wilson LA, Stulting RD. Phototherapeutic keratectomy for the treatment of nodular subepithelial corneal scars in patients with keratoconus who are contact lens intolerant Clao J. 1995;21:130–2
75. Lu CK, Chen KH, Lee SM, Hsu WM, Lai JY, Li YS. Herpes simplex keratitis following excimer laser application J Refract Surg. 2006;22:509–11
76. Hersh PS, Spinak A, Garrana R, Mayers M. Phototherapeutic keratectomy: Strategies and results in 12 eyes Refract Corneal Surg. 1993;9:S90–5
77. Faschinger CW. Phototherapeutic keratectomy of a corneal scar due to presumed infection after photorefractive keratectomy J Cataract Refract Surg. 2000;26:296–300
78. Rapuano CJ. Excimer laser phototherapeutic keratectomy: Long-term results and practical considerations Cornea. 1997;16:151–7
79. Elsahn AF, Rapuano CJ, Antunes VA, Abdalla YF, Cohen EJ. Excimer laser phototherapeutic keratectomy for keratoconus nodules Cornea. 2009;28:144–7
80. Lin CP, Chang CW, Su CY. Phototherapeutic keratectomy in treating keratomycosis Cornea. 2005;24:262–8
81. Kandori M, Inoue T, Shimabukuro M, Hayashi H, Hori Y, Maeda N, et al Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy Cornea. 2010;29:1199–202
82. Taenaka N, Fukuda M, Hibino T, Kato Y, Arimura E, Ishii Y, et al Surgical therapies for Acanthamoeba keratitis by phototherapeutic keratectomy and deep lamellar keratoplasty Cornea. 2007;26:876–9
83. Lindbohm N, Moilanen JA, Vesaluoma MH, Tervo TM. Acinetobacter
and Staphylococcus aureus
ulcerative keratitis after laser in situ
keratomileusis treated with antibiotics and phototherapeutic keratectomy J Refract Surg. 2005;21:404–6
84. Fagerholm P, Ohman L, Orndahl M. Phototherapeutic keratectomy in herpes simplex keratitis: Clinical results in 20 patients Acta Ophthalmol (Copenh). 1994;72:457–60
85. Camellin M, Arba Mosquera S. Simultaneous aspheric wavefront-guided transepithelial photorefractive keratectomy and phototherapeutic keratectomy to correct aberrations and refractive errors after corneal surgery J Cataract Refract Surg. 2010;36:1173–80
86. Vinciguerra P, Camesasca FI. Custom phototherapeutic keratectomy with intraoperative topography J Refract Surg. 2004;20:S555–63
87. Rapuano CJ. Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: Short-term clinical outcomes with and without an antihyperopia treatment and poor effectiveness of ultrasound biomicroscopic evaluation Cornea. 2005;24:20–31
88. Wirbelauer C, Scholz C, Haberle H, Laqua H, Pham DT. Corneal optical coherence tomography before and after phototherapeutic keratectomy for recurrent epithelial erosions(2) J Cataract Refract Surg. 2002;28:1629–35
89. Kornmehl EW, Steinert RF, Puliafito CA. A comparative study of masking fluids for excimer laser phototherapeutic keratectomy Arch Ophthalmol. 1991;109:860–3
90. Binder PS, Anderson JA, Rock ME, Vrabec MP. Human excimer laser keratectomy: Clinical and histopathologic correlations Ophthalmology. 1994;101:979–89
91. Rapuano CJ. Phototherapeutic keratectomy: Who are the best candidates and how do you treat them? Curr Opin Ophthalmol. 2010;21:280–2
92. Stewart OG, Pararajasegaram P, Cazabon J, Morrell AJ. Visual and symptomatic outcome of excimer phototherapeutic keratectomy (PTK) for corneal dystrophies Eye. 2002;16:126–31
93. Ha BJ, Kim TI, Choi SI, Stulting RD, Lee DH, Cho HS, et al Mitomycin C does not inhibit exacerbation of granular corneal dystrophy type II induced by refractive surface ablation Cornea. 2010;29:490–6
94. Lohmann CP, Sachs H, Marshall J, Gabel VP. Excimer laser phototherapeutic keratectomy for recurrent erosions: A clinical study Ophthalmic Surg Lasers. 1996;27:768–72
95. Forster W, Ratkay I, Krueger R, Busse H. Topical diclofenac sodium after excimer laser phototherapeutic keratectomy J Refract Surg. 1997;13:311–3
96. Feiz V, Oberg TJ, Kurz CJ, Mamalis N, Moshirfar M. Nepafenac-associated bilateral corneal melt after photorefractive keratectomy Cornea. 2009;28:948–50
97. Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: A review of current indications in the management of ophthalmic disorders Indian J Ophthalmol. 2007;55:251–60
98. Wang MX, Gray TB, Park WC, Prabhasawat P, Culbertson W, Forster R, et al Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits J Cataract Refract Surg. 2001;27:310–9
99. Choi YS, Kim JY, Wee WR, Lee JH. Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy Cornea. 1998;17:389–95
100. Lee HK, Kim JK, Kim EK, Kim GO, Lee IS. Phototherapeutic keratectomy with amniotic membrane for severe subepithelial fibrosis following excimer laser refractive surgery J Cataract Refract Surg. 2003;29:1430–5
101. Talu H, Tasindi E, Ciftci F, Yildiz TF. Excimer laser phototherapeutic keratectomy for recurrent pterygium J Cataract Refract Surg. 1998;24:1326–32
102. Walkow T, Daniel J, Meyer CH, Rodrigues EB, Mennel S. Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C Cornea. 2005;24:378–81
103. Park KA, Ki CS, Chung ES, Chung TY. Deep anterior lamellar keratoplasty in Korean patients with Avellino dystrophy Cornea. 2007;26:1132–5
104. Szentmary N, Langenbucher A, Hafner A, Seitz B. Impact of phototherapeutic keratectomy on the outcome of subsequent penetrating keratoplasty in patients with stromal corneal dystrophies Am J Ophthalmol. 2004;137:301–7
105. Hongyok T, Kim A, Jun AS, Ladas JG, Chuck RS. Phototherapeutic keratectomy with mitomycin C after Descemet stripping automated endothelial keratoplasty Br J Ophthalmol. 2010;94:377–8
106. Dogru M, Katakami C, Yamanaka A. Refractive changes after excimer laser phototherapeutic keratectomy J Cataract Refract Surg. 2001;27:686–92
107. Kremer I, Blumenthal M. Combined PRK and PTK in myopic patients with recurrent corneal erosion Br J Ophthalmol. 1997;81:551–4
108. Stark WJ, Chamon W, Kamp MT, Enger CL, Rencs EV, Gottsh JD. Clinical follow-up of 193-nm ArF excimer laser photokeratectomy Ophthalmology. 1992;99:805–12
109. Dougherty PJ, Wellish KL, Maloney RK. Excimer laser ablation rate and corneal hydration Am J Ophthalmol. 1994;118:169–76
110. Goldstein MH, Feistmann JA, Bhatti MT. PRK-pTK as a treatment for a patient with Thygeson's superficial punctate keratopathy Clao J. 2002;28:172–3
111. Leu G, Hersh PS. Phototherapeutic keratectomy for the treatment of diffuse lamellar keratitis J Cataract Refract Surg. 2002;28:1471–4
112. al-Rajhi AA, Wagoner MD, Badr IA, al-Saif A, Mahmood M. Bacterial keratitis following phototherapeutic keratectomy J Refract Surg. 1996;12:123–7
113. Deai T, Fukuda M, Tomoda Y, Higaki S, Hayashi K, Shimomura Y. Excimer laser photokeratectomy reactivates latent herpes simplex virus Jpn J Ophthalmol. 2004;48:570–2
114. Vrabec MP, Anderson JA, Rock ME, Binder PS, Steinert RF, Durrie DS, et al Electron microscopic findings in a cornea with recurrence of herpes simplex keratitis after excimer laser phototherapeutic keratectomy Clao J. 1994;20:41–4
115. Starr MB. Recurrent subepithelial corneal opacities after excimer laser phototherapeutic keratectomy Cornea. 1999;18:117–20
116. Pepose JS, Laycock KA, Miller JK, Chansue E, Lenze EJ, Gans LA, et al Reactivation of latent herpes simplex virus by excimer laser photokeratectomy Am J Ophthalmol. 1992;114:45–50
117. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs Ophthalmology. 2001;108:936–44
118. Miyata K, Takahashi T, Tomidokoro A, Ono K, Oshika T. Iatrogenic keratectasia after phototherapeutic keratectomy Br J Ophthalmol. 2001;85:247–8
119. Pfister RR. Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin: A case report Cornea. 2004;23:744–7
120. Epstein RJ, Robin JB. Corneal graft rejection episode after excimer laser phototherapeutic keratectomy Arch Ophthalmol. 1994;112:7
121. Hersh PS, Jordan AJ, Mayers M. Corneal graft rejection episode after excimer laser phototherapeutic keratectomy Arch Ophthalmol. 1993;111:735–6
Source of Support: Nil.
Conflict of Interest: None declared.